388 related articles for article (PubMed ID: 26751109)
21. Functional capacity evaluation of patients with mucopolysaccharidosis.
Guarany NR; Schwartz IV; Guarany FC; Giugliani R
J Pediatr Rehabil Med; 2012; 5(1):37-46. PubMed ID: 22543891
[TBL] [Abstract][Full Text] [Related]
22. Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis.
McGrath O; Sornalingam K; Aslam T; Ashworth J
Cornea; 2023 Aug; 42(8):992-999. PubMed ID: 36857777
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy for Mucopolysaccharidoses.
Sawamoto K; Chen HH; Alméciga-Díaz CJ; Mason RW; Tomatsu S
Mol Genet Metab; 2018 Feb; 123(2):59-68. PubMed ID: 29295764
[TBL] [Abstract][Full Text] [Related]
24. Mucopolysaccharidoses and the eye.
Ashworth JL; Biswas S; Wraith E; Lloyd IC
Surv Ophthalmol; 2006; 51(1):1-17. PubMed ID: 16414358
[TBL] [Abstract][Full Text] [Related]
25. Possible strategies to cross the blood-brain barrier.
Bellettato CM; Scarpa M
Ital J Pediatr; 2018 Nov; 44(Suppl 2):131. PubMed ID: 30442184
[TBL] [Abstract][Full Text] [Related]
26. [Principles of therapeutic approaches for mucopolysaccharidoses].
Caillaud C
Arch Pediatr; 2014 Jun; 21 Suppl 1():S39-45. PubMed ID: 25063383
[TBL] [Abstract][Full Text] [Related]
27. Enzyme replacement combinational therapy: effective treatments for mucopolysaccharidoses.
Safary A; Moghaddas-Sani H; Akbarzadeh-Khiavi M; Khabbazzi A; Rafi MA; Omidi Y
Expert Opin Biol Ther; 2021 Sep; 21(9):1181-1197. PubMed ID: 33653197
[TBL] [Abstract][Full Text] [Related]
28. Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations.
Parini R; Deodato F
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340185
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Options for Mucopolysaccharidoses: Current and Emerging Treatments.
Sawamoto K; Stapleton M; Alméciga-Díaz CJ; Espejo-Mojica AJ; Losada JC; Suarez DA; Tomatsu S
Drugs; 2019 Jul; 79(10):1103-1134. PubMed ID: 31209777
[TBL] [Abstract][Full Text] [Related]
30. Novel Enzyme Replacement Therapies for Neuropathic Mucopolysaccharidoses.
Sato Y; Okuyama T
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936354
[TBL] [Abstract][Full Text] [Related]
31. Current and Emerging Therapies for Mucopolysaccharidoses.
Lagler FB
Handb Exp Pharmacol; 2020; 261():39-56. PubMed ID: 31451968
[TBL] [Abstract][Full Text] [Related]
32. Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future.
Taylor M; Khan S; Stapleton M; Wang J; Chen J; Wynn R; Yabe H; Chinen Y; Boelens JJ; Mason RW; Kubaski F; Horovitz DDG; Barth AL; Serafini M; Bernardo ME; Kobayashi H; Orii KE; Suzuki Y; Orii T; Tomatsu S
Biol Blood Marrow Transplant; 2019 Jul; 25(7):e226-e246. PubMed ID: 30772512
[TBL] [Abstract][Full Text] [Related]
33. [Mucopolysaccharidosis and organ of sight].
Modrzejewska M; Kot J; Wiśniewska A; Romanowska H; Gizewska M
Klin Oczna; 2013; 115(2):152-7. PubMed ID: 24059034
[TBL] [Abstract][Full Text] [Related]
34. Cardiac involvement in MPS patients: incidence and response to therapy in an Italian multicentre study.
Sestito S; Rinninella G; Rampazzo A; D'Avanzo F; Zampini L; Santoro L; Gabrielli O; Fiumara A; Barone R; Volpi N; Scarpa M; Tomanin R; Concolino D
Orphanet J Rare Dis; 2022 Jun; 17(1):251. PubMed ID: 35768874
[TBL] [Abstract][Full Text] [Related]
35. A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses.
Frawley G; Fuenzalida D; Donath S; Yaplito-Lee J; Peters H
Paediatr Anaesth; 2012 Aug; 22(8):737-44. PubMed ID: 22381044
[TBL] [Abstract][Full Text] [Related]
36. Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologists.
Boffi L; Russo P; Limongelli G
Ital J Pediatr; 2018 Nov; 44(Suppl 2):122. PubMed ID: 30442163
[TBL] [Abstract][Full Text] [Related]
37. Ex Vivo and In Vivo Gene Therapy for Mucopolysaccharidoses: State of the Art.
Consiglieri G; Bernardo ME; Brunetti-Pierri N; Aiuti A
Hematol Oncol Clin North Am; 2022 Aug; 36(4):865-878. PubMed ID: 35773049
[TBL] [Abstract][Full Text] [Related]
38. Unique medical issues in adult patients with mucopolysaccharidoses.
Mitchell J; Berger KI; Borgo A; Braunlin EA; Burton BK; Ghotme KA; Kircher SG; Molter D; Orchard PJ; Palmer J; Pastores GM; Rapoport DM; Wang RY; White K
Eur J Intern Med; 2016 Oct; 34():2-10. PubMed ID: 27296591
[TBL] [Abstract][Full Text] [Related]
39. Mucopolysaccharidosis type III (Sanfilippo Syndrome): emerging treatment strategies.
de Ruijter J; Valstar MJ; Wijburg FA
Curr Pharm Biotechnol; 2011 Jun; 12(6):923-30. PubMed ID: 21235449
[TBL] [Abstract][Full Text] [Related]
40. Aortic root dilatation in patients with mucopolysaccharidoses and the impact of enzyme replacement therapy.
Poswar FO; de Souza CFM; Giugliani R; Baldo G
Heart Vessels; 2019 Feb; 34(2):290-295. PubMed ID: 30136169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
